Historical record - last NADAC publication: 5/17/2023

Product Information

TELMISARTAN 80 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.2685 per EA under NDC 59746044132. Its NADAC has been published 281 times since Jan 10, 2018.

The High Outlier badge above means this manufacturer's average price in the Telmisartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TELMISARTAN 80 MG TABLET

Telmisartan
$0.2685per EA
High Outlier

Strength

80 mg/1

NDC

59746044132

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

5/17/2023

Active Ingredients

TELMISARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA204164

On Market Since

8/22/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for TELMISARTAN 80 MG TABLET has been published 281 times since Jan 10, 2018, and over the history we have for it it has declined 34.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2685 per EA
All-time high$0.6664 (Mar 11, 2020)
All-time low$0.2383 (Jan 18, 2023)
Median price$0.3917
Average price$0.3984
Largest weekly change+41.6% (Nov 20, 2019)
Weeks tracked281
Tracking sinceJan 10, 2018

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-31.5%

All

-34.5%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN 80 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.2685 per EA (NDC 59746044132), effective May 24, 2023.

How has the price of TELMISARTAN 80 MG TABLET changed over time?

Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 34.5%. It has been tracked across 281 weekly CMS publications since Jan 10, 2018.

What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?

Since Jan 10, 2018, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.2383 (Jan 18, 2023) to a high of $0.6664 (Mar 11, 2020), with a median of $0.3917 per EA.

Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TELMISARTAN 80 MG TABLET, is $0.1485 per EA — about 45% below TELMISARTAN 80 MG TABLET.

Who manufactures TELMISARTAN 80 MG TABLET?

TELMISARTAN 80 MG TABLET (NDC 59746044132) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.